Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Topotecan As Consolidation Therapy in Ovarian Cancer
NCT00194935Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, sponsored by Weill Cornell Medicine. Started Feb 2003; status: terminated.
02
Drugs
topotecan
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00194935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194935.